Insider Transactions Reported by 15 Insiders of PharmaCyte Biotech, Inc.

Symbol
PMCB on Nasdaq
Location
Las Vegas, NV

Insiders trading volume in the past year

PharmaCyte Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua Silverman CEO and President, Director $397,694 +$80,476 +25% 05 Jan 2026
JONATHAN SCHECHTER Director $162,393 +$48,232 +42% 05 Jan 2026
ROBERT WEINSTEIN Director $42,075 25 Apr 2025
Michael M. Abecassis Director $23,417 25 Apr 2025
WAYNE WALKER Director $21,037 25 Apr 2025
Carlos Trujillo Chief Financial Officer, Director 20 Nov 2023
Matthias Loehr Director 31 Mar 2022
Daniel Stuart Farb Director 28 Dec 2022
Daniel Allen Director 28 Dec 2022
Gerald W. Crabtree Chief Science Officer, Director 10 Aug 2021
YUEN THOMAS C K Director 10 Aug 2021
JACK E. STOVER Director 15 Aug 2022
Thomas Liquard Director 10 Aug 2021
Kenneth L. Waggoner Chairman, CEO, Pres and GC, Director 10 Aug 2021
Raymond CF Tong Director 10 Aug 2021

Recent Insider Transactions by Companies or Individuals for PharmaCyte Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.